Leslie D. Funtleyder - Nov 10, 2022 Form 4 Insider Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

Role
Director
Signature
/s/ Narayan Prabhu, attorney-in-fact for Leslie D Funtleyder
Stock symbol
RVPH
Transactions as of
Nov 10, 2022
Transactions value $
$0
Form type
4
Date filed
11/14/2022, 08:00 AM
Previous filing
Aug 4, 2022
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVPH Stock Option (right to buy) Award $0 +3.9K $0.00 3.9K Nov 10, 2022 Common Stock, par value $0.0001 per share 3.9K $5.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan.